ClinicalTrials.Veeva

Menu

Assessment of Maternal and Perinatal Morbidity and Mortality in Vaginal and Cesarean Delivery

A

Alzahraa Ismail Ragheb Goda

Status

Unknown

Conditions

Delivery,Complication,Fetal
Delivery ,Complications,Maternal

Treatments

Procedure: cesarean delivery

Study type

Observational

Funder types

Other

Identifiers

NCT03666078
zahra2018

Details and patient eligibility

About

This study will be done at Ain Shams university maternity hospital to identify the significant risk of maternal intensive care unit admission, need for advanced surgery, postpartum hemorrhage, need for blood transfusion, febrile morbidity, neonatal intensive care unit admission (NICU), need for neonatal intubation and low APGAR scoring in both vaginal and cesarean section .and this will lead us to know if cesarean section rates in our unit is a safe alternative to vaginal delivery and which of both maneuvers will introduce fewer hazards to mother and fetus.

Full description

  • Type of Study: a cross-sectional study

  • Study Setting: Ain Shams maternity hospital

  • Study Period: 6 months

  • Study Population: in this prospective study, all women who deliver vaginally and by cesarean section at Ain Shams maternity hospital will be included.

  • Sampling Method: All of the pregnant women who will deliver vaginally and all of pregnant women who will deliver by cesarean sections in the labor delivery room at Ain Shams University Maternity Hospital on a fixed day and by a fixed team over a period of 6 months

  • Sample Size: all pregnant women who will deliver at Ain Shams maternity hospital.

  • Inclusion criteria :

    • All of the patients who will deliver vaginally
    • All of the patients who will deliver by cesarean sections.
  • Exclusion criteria: no exclusion criteria, all women who will attend for delivery will be included.

  • Ethical Considerations: the study objectives will be briefly and clearly described to all participants and an oral consent will be obtained from all patients.

  • Study Procedures :

In all selected cases the following will be recorded:

Parameters of maternal morbidity:

  1. ICU admission due to the complication of delivery.
  2. Need for advanced surgery (int. iliac ligation -hysterectomy -or due to the injury of pelvic organs).
  3. Febrile morbidity temp >38C on two or more occasion within 48h of delivery.
  4. Postpartum hemorrhage (blood loss 500cc in VD and 1liter in C\S).
  5. Wound infection.
  6. Late complications e.g. (D.V.T-puerperal sepsis and hematoma).
  7. Need for blood transfusion post labor
  8. Maternal mortality.

Parameters of fetal morbidity:

  1. Intracranial hemorrhage as compilations of delivery.

  2. Neonatal ICU admission as compilations of delivery

  3. Fracture (Femur, ribs, and humorous)

  4. Meconium aspiration.

  5. Erb's palsy.

  6. APGARscore1-5.

  7. Need for intubation during resuscitation.

    • Statistical analysis The patient will be subdivided into 4 groups, normal VD, instrumental VD, emergency C\S, and elective C\S The data has been collected in analytical sheet tabulated and statistical analysis using the following tests

1- T-test. 2- Chi-square test. 3- Fisher exact test

Statistical package :

data analysis will be performed by SPSS 16.0 using descriptive statistics tools, including mean, standard deviation and figures.A t-test will be used to compare mean values of the two groups .P-values, smaller than 0.05, were considered statistically significant.

Enrollment

100 estimated patients

Sex

Female

Ages

18 to 48 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All of the patients who will deliver vaginally
  • All of the patients who will deliver by cesarean sections.

Exclusion criteria

  • no exclusion criteria, all women who will attend for delivery will be included.

Trial design

100 participants in 4 patient groups

normal vaginal delivery
assisted vaginal delivery
elective cesarean delivery
Treatment:
Procedure: cesarean delivery
emergency cesarean delivery
Treatment:
Procedure: cesarean delivery

Trial contacts and locations

1

Loading...

Central trial contact

Mohamed M Samy, MD; Ahmed N Shaker

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems